Ado-Trastuzumab Emtansine

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 969 publications

Rapid and Efficient Antibody-Drug Conjugate Design Using Mechanistic Bottom-Up Modeling from In Vitro to Human.

Rapid and Efficient Antibody-Drug Conjugate Design Using Mechanistic Bottom-Up Modeling from In Vitro to Human.

Journal: Bioconjugate chemistry
Published: June 19, 2026

Incidence of Clinically Significant Neutropenia and Complications Related to Antibody-Drug Conjugates: A Real-World Study at the University of California.

Incidence of Clinically Significant Neutropenia and Complications Related to Antibody-Drug Conjugates: A Real-World Study at the University of California.

Journal: Cancers
Published: April 01, 2026

The Changing Landscape of Breast Cancer Treatment.

The Changing Landscape of Breast Cancer Treatment.

Journal: Chirurgia (Bucharest, Romania : 1990)
Published: April 01, 2026

Next-generation antibody-drug conjugates in drug-resistant solid tumors: promise, toxicity, and the emerging challenge of acquired resistance.

Next-generation antibody-drug conjugates in drug-resistant solid tumors: promise, toxicity, and the emerging challenge of acquired resistance.

Journal: Annals of medicine and surgery (2012)
Published: March 24, 2026

Exceptional and Durable Complete Response to Ado-Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer: A Case Report.

Exceptional and Durable Complete Response to Ado-Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer: A Case Report.

Journal: Cureus
Published: January 30, 2026

Antibody-drug conjugate sequencing in HER2-positive metastatic breast cancer: Real-world outcomes of trastuzumab deruxtecan with and without prior T-DM1 exposure.

Antibody-drug conjugate sequencing in HER2-positive metastatic breast cancer: Real-world outcomes of trastuzumab deruxtecan with and without prior T-DM1 exposure.

Journal: Breast (Edinburgh, Scotland)
Published: January 21, 2026

Guidelines for managing adverse reactions to antibody-drug conjugates in breast cancer (2025 edition)

Guidelines for managing adverse reactions to antibody-drug conjugates in breast cancer (2025 edition)

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: January 15, 2026

Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancer.

Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 12, 2026

Focusing on toxicity management: Challenges and strategies for HER2-targeted antibody-drug conjugates in breast cancer.

Focusing on toxicity management: Challenges and strategies for HER2-targeted antibody-drug conjugates in breast cancer.

Journal: Breast (Edinburgh, Scotland)
Published: January 08, 2026

Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2-targeted antibody-drug conjugates in breast and ovarian cancer.

Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2-targeted antibody-drug conjugates in breast and ovarian cancer.

Journal: Current opinion in obstetrics & gynecology
Published: December 29, 2025

HER2 Antibody-Nanogel Conjugates: A High-Capacity, Antibody-Sparing Alternative to Antibody-Drug Conjugates.

HER2 Antibody-Nanogel Conjugates: A High-Capacity, Antibody-Sparing Alternative to Antibody-Drug Conjugates.

Journal: Nano letters
Published: December 23, 2025

Expression of HER2 in the eye and the potential for on-target side effects with antibody-drug conjugates.

Expression of HER2 in the eye and the potential for on-target side effects with antibody-drug conjugates.

Journal: Scientific reports
Published: December 19, 2025
Showing 1-12 of 969

Last Updated: 06/30/2026